Stockreport

Imprimis Pharmaceuticals to Present at the Canaccord Genuity 38th Annual Growth Conference on August 9, 2018

IMPRIMIS PHARMACEUTICALS  (IMMY) 
Last imprimis pharmaceuticals earnings: 5/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: imprimisrx.com
PDF SAN DIEGO, July 18, 2018 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today announced that its Chief E [Read more]